{{Rsnum
|rsid=3774923
|Gene=PPARGC1A
|Chromosome=4
|position=23793441
|Orientation=minus
|GMAF=0.09275
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PPARGC1A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 9.7 | 90.3
| HCB | 3.7 | 30.9 | 65.4
| JPT | 0.9 | 26.5 | 72.6
| YRI | 0.7 | 10.9 | 88.4
| ASW | 0.0 | 3.5 | 96.5
| CHB | 3.7 | 30.9 | 65.4
| CHD | 0.9 | 33.9 | 65.1
| GIH | 4.0 | 18.8 | 77.2
| LWK | 0.0 | 5.5 | 94.5
| MEX | 1.7 | 20.7 | 77.6
| MKK | 0.0 | 12.2 | 87.8
| TSI | 0.0 | 8.8 | 91.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=19828207
|Title=Evaluation of the association between the PPARGC1A genetic polymorphisms and type 2 diabetes in Han Chinese population
}}

{{PMID Auto
|PMID=18162502
|Title=PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study.
|OA=1
}}

{{PMID Auto
|PMID=18588668
|Title=Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}